RBR-9qks3pc招募中Unknown
Effect of testosterone replacement associated with bariatric surgery in men with obesity: a randomized trial
Hospital e Maternidade São Domingos0 个研究点开始时间: 2023年7月13日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
- 性别
- Male
入选标准
- •Patients with Body Mass Index - BMI > 35; weighing up to 180 kg; with low testosterone levels (<350 ng/dl); classified as hypogonadal; who voluntarily agreed to participate in the research, in addition to understanding and consenting to participation through the TCLE (Free and Informed Consent Form)
排除标准
- •Interest in fertility in the 6 months following therapy; diagnosis of active prostate or breast cancer; previous diagnosis of prostate cancer, with less than two years of curative treatment; previous diagnosis of breast cancer; severe voiding symptoms, translated through the IPSS score (International Prostatic Symptom Score) > 19; severe cardiopulmonary disease (eg unstable angina, recent myocardial infarction); personal or family history of thromboembolism; hematocrit above 48%; patients with implanted medical devices such as pacemakers or essential support devices such as monitors
研究者
相似试验
招募中
4 期
Study of effects of testosterone replacement therapy in hypogonadal men with type 2 diabetes mellitusCTRI/2019/09/021175Dr Ronak Gandhi
进行中（未招募）
1 期
The effect of testosterone replacement threapy in men using opioidsEUCTR2014-004729-42-DKOdense University Hospital, department M40
进行中（未招募）
1 期
A clinical trial for the effects of testosterone replacement therapy in male patients with hypogonadism on arterial function markersEUCTR2014-005179-10-GRCharalampos Vlachopoulos24
已完成
不适用
Effect of transdermal testosterone replacement in hypogonadal men with decreased insulin sensitivityHypogonadal men with decreased insulin sensitivityNutritional, Metabolic, EndocrineTesticular hypofunctionISRCTN45741714ProStrakan Pharmaceuticals (UK)320
进行中（未招募）
不适用
Effect of Transdermal Testosterone Replacement in Hypogonadal Men with either Metabolic Syndrome or Type 2 Diabetes Mellitus - TIMES 2Male hypogonadism is generally characterised by abnormally low serum testosterone levels. Symptoms include changes in mood, decreased bone mineral density, increased body fat, decreased muscle mass and strength and sexual dysfunction. A number of conditions can also be associated with decreased testosterone production including metabolic syndrome, type II diabetes mellitus, atherosclerosis, myocardial infarction and chronic heart failureEUCTR2005-002607-17-DEProstrakan Pharmaceuticals Ltd520